Zevra Therapeutics Inc (ZVRA)
8.59
+0.01
(+0.12%)
USD |
NASDAQ |
Dec 24, 12:04
Zevra Therapeutics Profit Margin (Quarterly): -899.2% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | -105.0% |
| Johnson & Johnson | 11.99% |
| Vanda Pharmaceuticals Inc | -11.17% |
| Zoetis Inc | 28.56% |
| Xeris Biopharma Holdings Inc | -29.00% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -159.9% |
| Return on Assets | -56.14% |
| Return on Invested Capital | -85.03% |
| Gross Profit Margin (Quarterly) | 37.67% |
| Operating Margin (Quarterly) | -739.0% |
| Return on Net Operating Assets | -113.3% |